AstraZeneca and Amgen’s Tezspire succeeds in Phase III nasal polyps trial
The companies’ monoclonal antibody met co-primary endpoints in a Phase III trial in patients with chronic rhinosinusitis with ...
Yahoo Finance55 分钟
TEZSPIRE met both co-primary endpoints in the Phase III WAYPOINT trial in patients with ...
Participants in the trial were symptomatic despite treatment with standard of care (intranasal corticosteroids [INCS]). 1 Dr. Joseph Han, Vice Chair of Rhinology & Endoscopic Sinus and Skull Base ...
Amgen, AstraZeneca post Phase 3 win for nasal polyps therapy
Amgen (AMGN) and AstraZeneca's (AZN) asthma therapy Tezspire hits main goals in the Phase 3 trial for chronic rhinosinusitis ...
AstraZeneca touts positive results from nasal polyp treatment study
AstraZeneca PLC on Friday said it received positive results from a trial of Tezspire as a treatment for chronic rhinosinusitis with nasal polyps. Chronic rhinosinusitis is a disorder characterised by ...
Is Your Toothache Actually a Sinus Infection? How to Tell—and Treat It
Sinus infections (also known as sinusitis) strike more than 30 million Americans each year. And if you’re one of them, you’re ...
FDA Proposes Ban on a 'Useless' Decongestant, Phenylephrine
THURSDAY, Nov. 7, 2024 (HealthDay News) -- More than a year after its advisory panel unanimously declared the drug ...
Urgent warning to millions who use popular over-the-counter cold and flu remedy that could ...
AS COLD and flu season hits, a GP has issued a warning over a common remedy that could cause symptoms to “come back with a ...